Across TCGA pan-cancer cohorts, MIR548U RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR548U’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR548U RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR548U is over-expressed in tumor.

STAD and BRCA are the cancer types where MIR548U tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR548U RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.254	.004	3	view →
BRCA	Female	All	+0.201	.045	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR548U RNA expression & survival · all MIR548U data types